Creating a toolkit to prevent youth overdoses
Adapting and Testing a Youth Overdose Prevention Toolkit
This study is creating a helpful toolkit to prevent overdoses in young people aged 12 to 24, giving doctors in pediatric settings the tools they need to provide support and resources like naloxone and education about safe practices.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of British Columbia NIH-funded |
| Lab location | 1 site (Vancouver, Canada) |
| Project ID | NIH-11055890 on NIH RePORTER |
What this research studies
This research aims to develop and test a youth overdose prevention toolkit tailored for adolescents and young adults aged 12 to 24. The toolkit will provide practical guidance for healthcare providers in pediatric settings, focusing on essential elements like naloxone distribution, harm reduction education, and medications for opioid use disorder. By engaging with communities in Boston and Vancouver, the project seeks to adapt existing evidence-based interventions to better meet the developmental needs of youth and improve their access to overdose prevention resources.
Who could benefit from this research
Good fit: Ideal candidates for this research include adolescents and young adults aged 12 to 24, particularly those from communities disproportionately affected by substance use and overdose.
Not a fit: Patients outside the age range of 12 to 24 or those not affected by substance use issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce overdose deaths among youth by providing effective prevention strategies in healthcare settings.
How similar studies have performed: Previous research has shown success in implementing harm reduction strategies in youth populations, indicating a promising foundation for this novel approach.
Where this research is happening
Vancouver, Canada
- University of British Columbia — Vancouver, Canada (Active)
Researchers
- Principal investigator: Fast, Danya — University of British Columbia
- Study coordinator: Fast, Danya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.